266 related articles for article (PubMed ID: 22545639)
1. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research.
Worley J
Issues Ment Health Nurs; 2012 May; 33(5):319-28. PubMed ID: 22545639
[TBL] [Abstract][Full Text] [Related]
2. Prescription drug monitoring programs and death rates from drug overdose.
Paulozzi LJ; Kilbourne EM; Desai HA
Pain Med; 2011 May; 12(5):747-54. PubMed ID: 21332934
[TBL] [Abstract][Full Text] [Related]
3. Doctor and pharmacy shopping for controlled substances.
Peirce GL; Smith MJ; Abate MA; Halverson J
Med Care; 2012 Jun; 50(6):494-500. PubMed ID: 22410408
[TBL] [Abstract][Full Text] [Related]
4. Prescription drug monitoring and dispensing of prescription opioids.
Brady JE; Wunsch H; DiMaggio C; Lang BH; Giglio J; Li G
Public Health Rep; 2014; 129(2):139-47. PubMed ID: 24587548
[TBL] [Abstract][Full Text] [Related]
5. The influence of prescription monitoring programs on chronic pain management.
Wang J; Christo PJ
Pain Physician; 2009; 12(3):507-15. PubMed ID: 19461820
[TBL] [Abstract][Full Text] [Related]
6. [Prescription drug monitoring programs in the United States of America].
El Burai Félix S; Mack K
Rev Panam Salud Publica; 2014 Oct; 36(4):270-6. PubMed ID: 25563153
[TBL] [Abstract][Full Text] [Related]
7. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians.
Irvine JM; Hallvik SE; Hildebran C; Marino M; Beran T; Deyo RA
J Pain; 2014 Jul; 15(7):747-55. PubMed ID: 24787089
[TBL] [Abstract][Full Text] [Related]
8. Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances.
Fass JA; Hardigan PC
J Manag Care Pharm; 2011; 17(6):430-8. PubMed ID: 21787028
[TBL] [Abstract][Full Text] [Related]
9. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
[TBL] [Abstract][Full Text] [Related]
10. Using Prescription Drug Monitoring Programs to Address Drug Abuse.
Hansen M
NCSL Legisbrief; 2015 Mar; 23(12):1-2. PubMed ID: 26173300
[TBL] [Abstract][Full Text] [Related]
11. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?
Smith RJ; Kilaru AS; Perrone J; Paciotti B; Barg FK; Gadsden SM; Meisel ZF
Pain Med; 2015 Jun; 16(6):1122-31. PubMed ID: 25688454
[TBL] [Abstract][Full Text] [Related]
12. Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine.
Pradel V; Frauger E; Thirion X; Ronfle E; Lapierre V; Masut A; Coudert C; Blin O; Micallef J
Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):36-43. PubMed ID: 19040199
[TBL] [Abstract][Full Text] [Related]
13. The Minnesota Prescription Monitoring Program.
Herman C
Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
[TBL] [Abstract][Full Text] [Related]
14. The prescription drug epidemic in the United States: a perfect storm.
Maxwell JC
Drug Alcohol Rev; 2011 May; 30(3):264-70. PubMed ID: 21545556
[TBL] [Abstract][Full Text] [Related]
15. Disclosure of Use and Abuse of Controlled Substances Among Psychiatric Outpatients.
De Marco Centeno P; Baig M; Lee SE; Lane CJ; Lagomasino IT
J Psychiatr Pract; 2015 Nov; 21(6):412-8. PubMed ID: 26554323
[TBL] [Abstract][Full Text] [Related]
16. Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database.
Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels S; Novak S
Res Social Adm Pharm; 2014; 10(2):285-96. PubMed ID: 23816495
[TBL] [Abstract][Full Text] [Related]
17. Physician perspectives on a pilot prescription monitoring program.
Barrett K; Watson A
J Pain Palliat Care Pharmacother; 2005; 19(3):5-13. PubMed ID: 16219606
[TBL] [Abstract][Full Text] [Related]
18. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain.
Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A
Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312
[TBL] [Abstract][Full Text] [Related]
19. Combating the prescription painkiller epidemic: a national prescription drug reporting program.
Shepherd J
Am J Law Med; 2014; 40(1):85-112. PubMed ID: 24844043
[TBL] [Abstract][Full Text] [Related]
20. Disclosure to participate in State Prescription Drug Monitoring Programs. Interim final rule.
Department of Veterans Affairs
Fed Regist; 2013 Feb; 78(28):9589-93. PubMed ID: 23476981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
